Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Trouw

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
The Netherlands Journal of Medicine|November 6, 2012
New biomarkers in rheumatoid arthritisA Willemze, R E M Toes, T W J Huizinga, et al.
Molecular Immunology|November 5, 2003
Immune deposition of C1q and anti-C1q antibodies in the kidney is dependent on the presence of glomerular IgGL A Trouw, J M G J Duijs, C van Kooten, et al.
RMD Open|December 19, 2022
Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individualsFrederique Ponchel, Laurence Duquenne, Xuanxiao Xie, et al.
Clinical and Experimental Immunology|March 26, 2003
Glomerular deposition of C1q and anti-C1q antibodies in mice following injection of antimouse C1q antibodiesL A Trouw, M A Seelen, J M G J Duijs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 12, 2001
Specific inhibition of the classical complement pathway by C1q-binding peptidesA Roos, A J Nauta, D Broers, et al.
Journal of Neuroimmunology|December 4, 2014
Complement activation in Glioblastoma multiforme pathophysiology: evidence from serum levels and presence of complement activation products in tumor tissueT A M Bouwens, L A Trouw, R Veerhuis, et al.
Lupus|June 3, 2016
Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosusC Magro-Checa, R A Schaarenburg, H J L Beaart, et al.
Annals of the Rheumatic Diseases|March 10, 2017
Identification of Lifelines participants at high risk for development of rheumatoid arthritisS Arends, L A Trouw, R E M Toes, et al.
The British Journal of Dermatology|April 29, 2021
Anti-C1q autoantibodies may not serve as an adequate biomarker for lung manifestations in systemic sclerosis: a single-centre, cross-sectional studyD J Dijkstra, S I E Liem, N M van Leeuwen, et al.
Clinical Immunology (Orlando, Fla.)|February 9, 2010
C-reactive protein in myocardial infarction binds to circulating microparticles but is not associated with complement activationP M van der Zee, E Biró, L A Trouw, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
The Netherlands Journal of Medicine|November 6, 2012
New biomarkers in rheumatoid arthritisA Willemze, R E M Toes, T W J Huizinga, et al.
Molecular Immunology|November 5, 2003
Immune deposition of C1q and anti-C1q antibodies in the kidney is dependent on the presence of glomerular IgGL A Trouw, J M G J Duijs, C van Kooten, et al.
RMD Open|December 19, 2022
Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individualsFrederique Ponchel, Laurence Duquenne, Xuanxiao Xie, et al.
Clinical and Experimental Immunology|March 26, 2003
Glomerular deposition of C1q and anti-C1q antibodies in mice following injection of antimouse C1q antibodiesL A Trouw, M A Seelen, J M G J Duijs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 12, 2001
Specific inhibition of the classical complement pathway by C1q-binding peptidesA Roos, A J Nauta, D Broers, et al.
Journal of Neuroimmunology|December 4, 2014
Complement activation in Glioblastoma multiforme pathophysiology: evidence from serum levels and presence of complement activation products in tumor tissueT A M Bouwens, L A Trouw, R Veerhuis, et al.
Lupus|June 3, 2016
Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosusC Magro-Checa, R A Schaarenburg, H J L Beaart, et al.
Annals of the Rheumatic Diseases|March 10, 2017
Identification of Lifelines participants at high risk for development of rheumatoid arthritisS Arends, L A Trouw, R E M Toes, et al.
The British Journal of Dermatology|April 29, 2021
Anti-C1q autoantibodies may not serve as an adequate biomarker for lung manifestations in systemic sclerosis: a single-centre, cross-sectional studyD J Dijkstra, S I E Liem, N M van Leeuwen, et al.
Clinical Immunology (Orlando, Fla.)|February 9, 2010
C-reactive protein in myocardial infarction binds to circulating microparticles but is not associated with complement activationP M van der Zee, E Biró, L A Trouw, et al.
Pageof 5